19 January 2021 | News
The data generated through the ECG device can be seen on the MyHealthcare app and seamlessly flows into the MyHealthcare EMR for doctors and caregivers, monitoring their patient’s health records
Source credit: Shutterstock
MyHealthcare and AliveCor have teamed up to allow patients to be able to read their ECG data directly from their KardiaMobile 6L device into the MyHealthcare platform. The FDA-cleared KardiaMobile device is the most clinically validated personal ECG solution in the world and the partnership will aim to help patients monitor their heart health at the comfort of their home. The association is a steppingstone in bringing to the market an integrated cardiac care programme.
The data generated through the ECG device can be seen on the MyHealthcare app and seamlessly flows into the MyHealthcare EMR for doctors and caregivers, monitoring their patient’s health records. The partnership will also bring to MyHealthcare patients integrated cardiac care programmes, which will allow patients to sign up through the MyHealthcare partner hospitals onto a care plan, which monitors their cardiac function, any outlier data and deliver alerts to the care team when needed and seek consult with cardiologists from MyHealthcare partner hospitals.
Lokesh Prasad, Managing Director, AliveCor India commented, “KardiaMobile serves a critical function in the need for remote patient management in India. Our devices use machine learning to detect arrhythmias quickly and efficiently with 98% sensitivity and 97% specificity. This gives patients and physicians fast and highly reliable data that can be easily used to influence a care plan.”
Commenting on the association, Shyatto Raha, Founder and Chief Executive Officer, MyHealthcare said, “The partnership with AliveCor and the integrated clinical data delivery to the doctors via the MyHealthcare EMR will help bring the platform a step closer to the in-OPD experience.”
The association is slated to be an industry-first and would essentially mean a giant leap for the telemedicine industry in India.